Back to Search
Start Over
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma.
- Source :
- Neuro-Oncology; Nov2010, Vol. 12 Issue 11, p1167-1172, 6p, 1 Diagram, 3 Charts, 1 Graph
- Publication Year :
- 2010
Details
- Language :
- English
- ISSN :
- 15228517
- Volume :
- 12
- Issue :
- 11
- Database :
- Complementary Index
- Journal :
- Neuro-Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 54655213
- Full Text :
- https://doi.org/10.1093/neuonc/noq100